Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1708 ARTÍCULOS , VIENDO DEL 1336 AL 1350
Integrated communications between cyclooxygenase-2 and Alzheimer's disease
Guan PP, Wang P.
FASEB J. 2019 Jan;33(1):13-33. doi: 10.1096/fj.201800355RRRR. Epub 2018 Jul 18.
Amyloid Plaques of Alzheimer's Disease as Hotspots of Glutamatergic Activity
Ovsepian SV, O'Leary VB, Zaborszky L, Ntziachristos V, Dolly JO.
Neuroscientist. 2019 Aug;25(4):288-297. doi: 10.1177/1073858418791128. Epub 2018 Jul 27.
Ottoboni G, Amici S, Iannizzi P, Di Pucchio A, Vanacore N, Chattat R; On the behalf of DEMCAREGIVER Group.
Aging Clin Exp Res. 2019 Apr;31(4):527-537. doi: 10.1007/s40520-018-0995-9. Epub 2018 Jul 31.
An Integrative Overview of Non-Amyloid and Non-Tau Pathologies in Alzheimer's Disease
Menta BW, Swerdlow RH.
Neurochem Res. 2019 Jan;44(1):12-21. doi: 10.1007/s11064-018-2603-y. Epub 2018 Aug 6.
Apathy in Preclinical Alzheimer's Disease: Psychometric Validation of the Apathy Evaluation Scale
Umucu E, Wyman M, Lee B, Zuelsdorff M, Benton SF, Nystrom N, Johnson SC, Carlsson CM, Asthana S, Gleason CE.
Am J Alzheimers Dis Other Demen. 2019 Feb;34(1):16-22. doi: 10.1177/1533317518794020. Epub 2018 Aug 14.
Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease
Baig AM.
ACS Chem Neurosci. 2019 Jan 16;10(1):21-24. doi: 10.1021/acschemneuro.8b00409. Epub 2018 Aug 30.
Long-term medical costs of Alzheimer's disease: matched cohort analysis
Sopina E, Spackman E, Martikainen J, Waldemar G, Sørensen J.
Eur J Health Econ. 2019 Apr;20(3):333-342. doi: 10.1007/s10198-018-1004-0. Epub 2018 Aug 31.
Brain Selenium in Alzheimer's Disease (BRAIN SEAD Study): a Systematic Review and Meta-Analysis
Varikasuvu SR, Prasad V S, Kothapalli J, Manne M.
Biol Trace Elem Res. 2019 Jun;189(2):361-369. doi: 10.1007/s12011-018-1492-x. Epub 2018 Aug 31.
Belger M, Haro JM, Reed C, Happich M, Argimon JM, Bruno G, Dodel R, Jones RW, Vellas B, Wimo A.
Eur J Health Econ. 2019 Apr;20(3):343-355. doi: 10.1007/s10198-018-1001-3. Epub 2018 Sep 3.
Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy
Iranifar E, Seresht BM, Momeni F, Fadaei E, Mehr MH, Ebrahimi Z, Rahmati M, Kharazinejad E, Mirzaei H.
J Cell Physiol. 2019 Mar;234(3):2296-2305. doi: 10.1002/jcp.27214. Epub 2018 Sep 7.
Van Stavern GP, Bei L, Shui YB, Huecker J, Gordon M.
Br J Ophthalmol. 2019 Jul;103(7):971-975. doi: 10.1136/bjophthalmol-2018-312425. Epub 2018 Sep 11.
Redox proteomics and amyloid β-peptide: insights into Alzheimer disease
Butterfield DA, Boyd-Kimball D.
J Neurochem. 2019 Nov;151(4):459-487. doi: 10.1111/jnc.14589. Epub 2018 Nov 27.
Understanding the Role of ApoE Fragments in Alzheimer's Disease
Muñoz SS, Garner B, Ooi L.
Neurochem Res. 2019 Jun;44(6):1297-1305. doi: 10.1007/s11064-018-2629-1. Epub 2018 Sep 17.
The leukotriene signaling pathway: a druggable target in Alzheimer's disease
Michael J, Marschallinger J, Aigner L.
Drug Discov Today. 2019 Feb;24(2):505-516. doi: 10.1016/j.drudis.2018.09.008. Epub 2018 Sep 18.
Involvement of calpain in the neuropathogenesis of Alzheimer's disease
Mahaman YAR, Huang F, Kessete Afewerky H, Maibouge TMS, Ghose B, Wang X.
Med Res Rev. 2019 Mar;39(2):608-630. doi: 10.1002/med.21534. Epub 2018 Sep 10.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.